Antiviral Activity of MK-4965, a Novel Nonnucleoside Reverse Transcriptase InhibitorLAI, Ming-Tain; MUNSHI, Vandna; TOUCH, Sinoeun et al.Antimicrobial agents and chemotherapy. 2009, Vol 53, Num 6, pp 2424-2431, issn 0066-4804, 8 p.Article

How common is the non-nucleoside reverse transcriptase inhibitor mutation E138K in clinical practice?BRADSHAW, Daniel; MANDALIA, Sundhiya; NELSON, Mark et al.The Journal of infection. 2011, Vol 63, Num 2, pp 172-173, issn 0163-4453, 2 p.Article

Compilation and prevalence of mutations associated with resistance to non-nucleoside reverse transcriptase inhibitorsTAMBUYZER, Lotke; AZIJN, Hilde; RIMSKY, Laurence T et al.Antiviral therapy (London). 2009, Vol 14, Num 1, pp 103-109, issn 1359-6535, 7 p.Article

Non-nucleoside reverse transcriptase inhibitors : a reviewWATERS, L; JOHN, L; NELSON, M et al.International journal of clinical practice (Esher). 2007, Vol 61, Num 1, pp 105-118, issn 1368-5031, 14 p.Article

Pre-existing mutations in the rilpivirine Phase III trials ECHO and THRIVE: prevalence and impact on virological responseVINGERHOETS, Johan; RIMSKY, Laurence; VAN EYGEN, Veerle et al.Antiviral therapy (London). 2013, Vol 18, Num 2, pp 253-256, issn 1359-6535, 4 p.Article

Lack of Pharmacokinetic Interaction between Rilpivirine and Integrase Inhibitors Dolutegravir and GSK1265744FORD, Susan L; GOULD, Elizabeth; SHUGUANG CHEN et al.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 11, pp 5472-5477, issn 0066-4804, 6 p.Article

Rilpivirine Inhibits Drug Transporters ABCB1, SLC22A1, and SLC22A2 In VitroMOSS, Darren M; LIPTROTT, Neill J; CURLEY, Paul et al.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 11, pp 5612-5618, issn 0066-4804, 7 p.Article

In search of effective anti-HHV-6 agentsDE CLERCQ, Erik; NAESENS, Lieve.Journal of clinical virology. 2006, Vol 37, issn 1386-6532, S82-S86, SUP1Conference Paper

Antiviral Activity and In Vitro Mutation Development Pathways of MK-6186, a Novel Nonnucleoside Reverse Transcriptase InhibitorMEIQING LU; FELOCK, Peter J; WILLIAMS, Theresa M et al.Antimicrobial agents and chemotherapy. 2012, Vol 56, Num 6, pp 3324-3335, issn 0066-4804, 12 p.Article

96-Week resistance analyses of rilpivirine in treatment-naive, HIV-1-infected adults from the ECHO and THRIVE Phase III trialsRIMSKY, Laurence; VAN EYGEN, Veerle; HOOGSTOEL, Annemie et al.Antiviral therapy (London). 2013, Vol 18, Num 8, pp 967-977, issn 1359-6535, 11 p.Article

Mechanistic Characterization of GS-9190 (Tegobuvir), a Novel Nonnucleoside Inhibitor of Hepatitis C Virus NS5B PolymeraseSHIH, I-Hung; VLIEGEN, Inge; XIAOPING QI et al.Antimicrobial agents and chemotherapy. 2011, Vol 55, Num 9, pp 4196-4203, issn 0066-4804, 8 p.Article

Viral resuppression and detection of drug resistance following interruption of a suppressive non-nucleoside reverse transcriptase inhibitor-based regimenFOX, Zoe; PHILLIPS, Andrew; COHERE, Cal et al.AIDS (London). 2008, Vol 22, Num 17, pp 2279-2289, issn 0269-9370, 11 p.Article

Frequent methamphetamine use is associated with primary non-nucleoside reverse transcriptase inhibitor resistanceNASH COLFAX, Grant; VITTINGHOFF, Eric; GRANT, Robert et al.AIDS (London). 2007, Vol 21, Num 2, pp 239-241, issn 0269-9370, 3 p.Article

Lactic acidemia in infection with human immunodeficiency virusCARR, Andrew.Clinical infectious diseases. 2003, Vol 36, pp S96-S100, issn 1058-4838, SUP2Article

Nonnucleoside Inhibitors of Norovirus RNA Polymerase: Scaffolds for Rational Drug DesignELTAHLA, Auda A; KUN LEE LIM; EDEN, John-Sebastian et al.Antimicrobial agents and chemotherapy. 2014, Vol 58, Num 6, pp 3115-3123, issn 0066-4804, 9 p.Article

Second-line protease inhibitor-based antiretroviral therapy after non-nucleoside reverse transcriptase inhibitor failure: the effect of a nucleoside backboneWATERS, Laura; BANSI, Loveleen; ASBOE, David et al.Antiviral therapy (London). 2013, Vol 18, Num 2, pp 213-219, issn 1359-6535, 7 p.Article

Safety and Efficacy of GSK2248761, a Next-Generation Nonnucleoside Reverse Transcriptase Inhibitor, in Treatment-Naive HIV-1-Infected SubjectsZALA, Carlos; CLAIR, Marty St; MAYERS, Douglas et al.Antimicrobial agents and chemotherapy. 2012, Vol 56, Num 5, pp 2570-2575, issn 0066-4804, 6 p.Article

A Domino Microwave-Assisted Protocol for the Synthesis of 2,6-Disubstituted PyrimidinonesRADI, Marco; CASALUCE, Gianni; BOTTA, Maurizio et al.Synlett (Stuttgart). 2011, Num 14, pp 1997-2000, issn 0936-5214, 4 p.Article

Antiretroviral drug interactions: often unrecognized, frequently unavoidable, sometimes unmanageableSEDEN, Kay; BACK, David; KHOO, Saye et al.Journal of antimicrobial chemotherapy (Print). 2009, Vol 64, Num 1, pp 5-8, issn 0305-7453, 4 p.Article

Prevalence and risk factors for etravirine resistance among patients failing on non-nucleoside reverse transcriptase inhibitorsLAPADULA, Giuseppe; CALABRESI, Alessandra; TORTI, Carlo et al.Antiviral therapy (London). 2008, Vol 13, Num 4, pp 601-605, issn 1359-6535, 5 p.Article

Phenotypic impact of resistance mutations on etravirine susceptibility in HIV patients with prior failure to nonnucleoside analoguesPOVEDA, Eva; DE MENDOZA, Carmen; PATTERY, Theresa et al.AIDS (London). 2008, Vol 22, Num 17, pp 2395-2398, issn 0269-9370, 4 p.Article

Considerations on the effectiveness of nevirapine in protease inhibitor-based regimen simplificationMARTINEZ, Esteban; GATELL, Jose M.AIDS (London). 2007, Vol 21, Num 13, pp 1829-1830, issn 0269-9370, 2 p.Article

Nonnucleoside inhibitor of measles virus RNA-dependent RNA polymerase complex activityWHITE, Laura K; YOON, Jeong-Joong; LEE, Jin K et al.Antimicrobial agents and chemotherapy. 2007, Vol 51, Num 7, pp 2293-2303, issn 0066-4804, 11 p.Article

Adherence-resistance relationships for protease and non-nucleoside reverse transcriptase inhibitors explained by virological fitnessBANGSBERG, David R; ACOSTA, Edward P; GUPTA, Reena et al.AIDS (London). 2006, Vol 20, Num 2, pp 223-231, issn 0269-9370, 9 p.Article

Thiourea-based non-nucleoside inhibitors of HIV reverse transcriptase as bifunctional organocatalysts in the asymmetric Strecker synthesisTSOGOEVA, Svetlana B; HATELEY, Martin J; YALALOV, Denis A et al.Bioorganic & medicinal chemistry. 2005, Vol 13, Num 19, pp 5680-5685, issn 0968-0896, 6 p.Article